1 – 33 of 33
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
BioMEL : a translational research biobank of melanocytic lesions and melanoma
(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
- 2023
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
(
- Contribution to journal › Article
-
Mark
Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells
(
- Contribution to journal › Article
- 2022
-
Mark
Dialysis as a Novel Adjuvant Treatment for Malignant Cancers
(
- Contribution to journal › Scientific review
-
Mark
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
(
- Contribution to journal › Article
- 2021
-
Mark
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
(
- Contribution to journal › Article
-
Mark
Non-radical primary diagnostic biopsies affect survival in cutaneous head and neck melanoma
(
- Contribution to journal › Article
-
Mark
Surgery of metastatic melanoma after systemic therapy–the SUMMIST trial : study protocol for a randomized controlled trial
(
- Contribution to journal › Letter
- 2020
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
(
- Contribution to journal › Article
-
Mark
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
(
- Contribution to journal › Article
-
Mark
Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
(
- Contribution to journal › Article
-
Mark
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
(
- Contribution to journal › Article
- 2019
-
Mark
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study) : Protocol for a multicenter phase II open label study
(
- Contribution to journal › Article
-
Mark
A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden
(
- Contribution to journal › Article
-
Mark
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
(
- Contribution to journal › Article
- 2018
-
Mark
Rescue Effect Inherited in Colony Formation Assays Affects Radiation Response
(
- Contribution to journal › Article
- 2017
-
Mark
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
(
- Contribution to journal › Article
-
Mark
Hypoxia-inducible factor 1a predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall
(
- Contribution to journal › Article
-
Mark
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
(
- Contribution to journal › Article
- 2016
-
Mark
Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma
(
- Contribution to journal › Article
- 2015
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
- 2014
-
Mark
Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome.
(
- Contribution to journal › Article
-
Mark
Discovery-based Protein Expression Profiling Identifies Distinct Subgroups and Pathways in Leiomyosarcomas.
(
- Contribution to journal › Article
- 2013
-
Mark
The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
(
- Contribution to journal › Article
- 2012
-
Mark
Prognostic value of proliferation in pleomorphic soft tissue sarcomas: a new look at an old measure.
2012) In Human Pathology(
- Contribution to journal › Article
- 2011
-
Mark
Refined diagnosis and prognosis in soft tissue sarcoma - genetic profiles, biomarkers and prognostic models
(
- Thesis › Doctoral thesis (compilation)
-
Mark
A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth pattern.
(
- Contribution to journal › Article
-
Mark
Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas.
(
- Contribution to journal › Article
- 2009
-
Mark
Genetic profiling - implications for refined diagnosis and treatment of soft tissue sarcomas
(
- Contribution to journal › Article
-
Mark
Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
(
- Contribution to journal › Article
- 2008
-
Mark
Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer
(
- Contribution to journal › Article
-
Mark
Genetic profiling differentiates second primary tumors from metastases in adult metachronous soft tissue sarcoma.
(
- Contribution to journal › Article